Titan Pharmaceuticals Inc (TTNP)
3.92
-0.11
(-2.73%)
USD |
NASDAQ |
Nov 05, 11:30
Titan Pharmaceuticals Total Liabilities (Quarterly): 0.356M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.356M |
March 31, 2024 | 0.559M |
December 31, 2023 | 1.444M |
September 30, 2023 | 1.866M |
June 30, 2023 | 1.846M |
March 31, 2023 | 2.48M |
December 31, 2022 | 2.695M |
September 30, 2022 | 2.726M |
June 30, 2022 | 2.652M |
March 31, 2022 | 2.436M |
December 31, 2021 | 2.856M |
September 30, 2021 | 2.141M |
June 30, 2021 | 2.76M |
March 31, 2021 | 3.844M |
December 31, 2020 | 4.555M |
September 30, 2020 | 8.915M |
June 30, 2020 | 8.202M |
March 31, 2020 | 7.986M |
December 31, 2019 | 8.089M |
September 30, 2019 | 7.964M |
June 30, 2019 | 7.332M |
March 31, 2019 | 8.385M |
December 31, 2018 | 7.264M |
September 30, 2018 | 6.365M |
June 30, 2018 | 5.93M |
Date | Value |
---|---|
March 31, 2018 | 6.136M |
December 31, 2017 | 8.048M |
September 30, 2017 | 8.702M |
June 30, 2017 | 1.876M |
March 31, 2017 | 2.467M |
December 31, 2016 | 5.476M |
September 30, 2016 | 8.273M |
June 30, 2016 | 7.618M |
March 31, 2016 | 6.52M |
December 31, 2015 | 6.297M |
September 30, 2015 | 5.992M |
June 30, 2015 | 15.33M |
March 31, 2015 | 14.20M |
December 31, 2014 | 12.24M |
September 30, 2014 | 8.965M |
June 30, 2014 | 10.79M |
March 31, 2014 | 11.84M |
December 31, 2013 | 12.66M |
September 30, 2013 | 14.50M |
June 30, 2013 | 14.76M |
March 31, 2013 | 26.58M |
December 31, 2012 | 47.96M |
September 30, 2012 | 37.88M |
June 30, 2012 | 33.05M |
March 31, 2012 | 31.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.356M
Minimum
Jun 2024
8.915M
Maximum
Sep 2020
3.600M
Average
2.695M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
AIM ImmunoTech Inc | 9.613M |
Perspective Therapeutics Inc | 44.92M |
Protalix BioTherapeutics Inc | 62.96M |
Electromed Inc | 7.689M |
Armata Pharmaceuticals Inc | 154.41M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.35M |
Shareholders Equity (Quarterly) | 3.994M |